Request Call Back

Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What additional medications were you taking at the time?

Was Gemfibrozil (Lopid) taken while taking Baycol?

Has Rhabdomyolysis been diagnosed?

Have any of the following side effects occurred?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Baycol Side Effects Lawsuits | Side Effects: Rhabdomyolysis, Muscle Pain, Weakness, Tenderness, Malaise, Fever, Nausea, Vomiting

Baycol Side Effects May Link To Rhabdomyolysis Lawsuits

Baycol | Lawsuits, Lawyers | Side Effects: Rhabdomyolysis, Muscle Pain, Weakness, Tenderness, Malaise, Fever, Nausea, Vomiting

Baycol Side Effects

Baycol (generic: cerivastatin) was approved in the United States in 1997. Baycol is part of a class of drugs used to lower cholesterol levels called statins. In August 2001, Baycol was pulled from the market. Baycol was withdrawn from the market because it has been linked to Rhabdomyolysis, which caused 31 deaths in the United States.

What Is Rhabdomyolysis?

Rhabdomyolysis is a condition that causes muscle-cell breakdown (atrophy) and causes muscle pain, weakness, tenderness, malaise, fever, dark urine, nausea and vomiting. Rhabdomyolysis is a potentially life threatening condition.

While all statins have been associated with very rare reports of rhabdomyolysis, cases of fatal rhabdomyolysis in association with the use of Baycol have been reported significantly more frequently than for other approved statins," the FDA said.

Rhabdomyolysis involves injuries to the kidneys caused by toxic effects of the contents of muscle cells. Myoglobin is an iron-containing pigment found in the skeletal muscle. When the skeletal muscle is damaged, the myoglobin is released into the bloodstream. It is filtered out of the bloodstream by the kidneys. Myoglobin may occlude the structures of the kidney, causing damage such as acute tubular necrosis or kidney failure. Myoglobin breaks down into potentially toxic compounds, which will also cause kidney failure.

Need Legal Help Regarding Baycol Side Effects?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).



BaycolRSS Feed

Baycol Class Action Lawsuit Allowed to Proceed

Jun 17, 2011
Thanks to a U.S. Supreme Court decision that was nearly unanimous, two West Virginians will be able to go forward with a Baycol class action lawsuit that seeks economic damages.  The decision overturns previous federal court rulings that prohibited a West Virginia state court from certifying the Baycol lawsuit as a class action.The West Virginia Baycol lawsuit was brought in September 2001, a month after Bayer pulled the cholesterol-lowering drug off the market because of its association...

Bayer's filings with SEC reveal two subpoenas

Mar 8, 2006 | Pittsburgh Post-Gazette
Bayer AG disclosed in filings with the Securities and Exchange Commission that it received subpoenas in two separate cases.The German-based drug and chemicals firm was subpoenaed by the Department of Justice last month in connection with alleged price-fixing of plastics products. Bayer said it was a defendant in multiple class-action lawsuits that have been consolidated in federal court in Kansas.Separately, the company was subpoenaed by the U.S. attorney in New Jersey in connection with an...

Bayer gets second subpoena over withdrawn Baycol drug

Mar 7, 2006 | AP
Bayer AG disclosed Monday that it received a subpoena from the U.S. attorney for New Jersey relating to its withdrawn Baycol/Cerivastatin anti-cholesterol drug, which has allegedly been linked to about 100 deaths.Bayer received the subpoena last month, according to the company's annual report filed with the federal Securities and Exchange Commission.The German-based pharmaceutical and chemical company had received a subpoena in January 2004 also related to its Baycol drug from the Defense...

Bad Day All Around for Bayer with Announcements of $1.1 Billion in Baycol-Related Settlements and the Indictment of Two Former Executives for Price-Fixing

Aug 12, 2005 |
Yesterday, Bayer AG, the German pharmaceutical and chemical giant, had the kind of bad-news day major corporations dread. On the pharmaceutical side, the company announced, that as of June 30, it has paid some $1.138 billion to settle 3,017 personal injury cases worldwide stemming from its ill-fate cholesterol drug, Baycol, which was pulled from the market in 2002 as a result of serious safety problems.The settlements have averaged about $378,000 and the company still faces significant exposure...

Bayer Pays 1.138 Bln Usd to Settle 3,017 Baycol Cases

Aug 10, 2005 | AFX
Bayer AG said that as of June 30 it has paid 1.138 bln usd to settle 3,017 cases worldwide related to its former cholesterol-lowering blockbuster drug Baycol (Lipobay), which was withdrawn from the market three years ago for safety reasons.The chemicals and pharmaceutical hybrid has paid on average 377,195 usd to settle each case.It said there are now 5,986 cases pending compared to 'fewer than 6,000' as announced at the annual general meeting.On May 10, Bayer said it had paid 1.133 bln usd to...

More Baycol News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo